HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a drug make stem cell transplants safer for blood cancer patients?
Disease control CompletedThis study tested a drug called palifermin in 34 adults with blood cancers who received stem cells from an unrelated donor. The goal was to see if palifermin could reduce severe graft-versus-host disease (GVHD), a common complication where donor cells attack the patient's body. P…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:21 UTC
-
Cancer drug shows promise in Hard-to-Treat lymphoma patients
Disease control CompletedThis study tested the drug pembrolizumab (Keytruda) given every 6 weeks in 66 adults whose Hodgkin's lymphoma or PMBCL had come back or not responded to prior treatment. The main goal was to see how many participants had their tumors shrink or disappear. Results showed that some …
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 04:20 UTC
-
PET scans could Fine-Tune chemo for hodgkin lymphoma patients
Disease control CompletedThis study tested whether using an early PET scan after two rounds of chemotherapy could help doctors choose the right treatment for people with advanced Hodgkin lymphoma. Patients whose scan showed a good response got a milder chemo, while those with less response continued stro…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New drug may replace harsh chemo before transplant for hodgkin lymphoma
Disease control CompletedThis study tested whether a targeted drug called brentuximab vedotin (SGN-35) could replace the standard ICE chemotherapy as the first step before a stem cell transplant in people with Hodgkin lymphoma that came back or didn't respond to initial treatment. 66 participants receive…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:54 UTC